Published on 02/12/2025

Change Histories and Model Cards in AI/ML Model Validation

Introduction to AI/ML Model Validation in GxP Analytics

The integration of artificial intelligence (AI) and machine learning (ML) into Good Practices (GxP) analytics is rapidly evolving, particularly within the pharmaceutical sector. As companies increasingly deploy AI/ML technologies to enhance efficiency, accuracy, and patient outcomes, it becomes imperative to navigate the regulatory landscape effectively. This requires a comprehensive understanding of documentation, model verification, and validation (V&V). This tutorial aims to outline the critical aspects of documentation, including change histories and model cards, to align with regulatory expectations under authorities such as the US FDA, EMA, and MHRA.

Understanding Regulatory Expectations for AI/ML in Pharmaceutical Industry

Regulatory bodies like the FDA, EMA, and MHRA emphasize the importance of robust validation processes for AI/ML technologies. Key regulations, such as 21 CFR Part 11 and EU Annex 11, provide a framework for electronic records and signatures, necessitating effective documentation and audit trails. The challenges posed by the unique nature of AI models—particularly concerning bias, fairness, and explainability (XAI)—mandate rigorous scrutiny during validation. Organizations must establish principles aligned with GAMP 5 guidelines, focusing on risk management related to the intended use of AI/ML models in clinical settings.

Create a Documentation Framework for AI/ML Models

A comprehensive documentation strategy is essential for maintaining compliance and ensuring as well as demonstrating the effective use of AI/ML models. The following steps guide professionals in developing a structured documentation framework:

• Step 1: Define the Intended Use of the Model

The intended use of the AI/ML model should be clearly articulated, including its role in decision-making processes. This requires a thorough understanding of how the model integrates with existing clinical workflows and the potential impact on patient care.

• Step 2: Conduct Data Readiness and Curation

The curation of data is vital for training and validating machine learning models. Conducting data readiness assessments helps ensure that data sources are reliable, relevant, and suitable for the model’s intended use. Documentation should capture the data provenance, cleaning procedures, and preprocessing steps.

• Step 3: Initiate Bias and Fairness Testing

To mitigate the risks associated with bias in AI/ML models, systematic testing must be carried out to evaluate fairness. Establish benchmarks reflecting demographic diversity and collect documentation that details the procedures followed in both bias identification and mitigation.

• Step 4: Model Verification and Validation

Model verification ensures that the model implementation meets the specified requirements. Subsequently, validation confirms that the model performs accurately in real-world conditions. Documentation must delineate the methodologies employed, including test case development and results obtained.

• Step 5: Change Histories and Model Cards

Maintaining a change history is essential for transparency and accountability. A model card serves as a comprehensive summary of the model, providing essential metrics such as performance, limitations, and the contextual use of the AI/ML application. Details about updates, adjustments, and versioning should also be meticulously documented.

• Step 6: Ensuring Explainability (XAI)

The ability to explain how models reach their conclusions is increasingly important. Documentation should outline the methodologies employed for explainability, including feature importance assessments and model interpretation techniques.

• Step 7: Drift Monitoring and Re-Validation

Models may degrade over time due to shifts in underlying data distributions—a phenomenon known as ‘drift.’ A strategy must be in place for continuous monitoring and periodic re-validation of the model. Documentation should reflect the scheduled monitoring activities and how drift impacts performance.

Implementing Governance and Security for AI/ML Models

AI governance is critical in the pharmaceutical context to support ethical considerations, compliance, and risk management. Establishing a governance framework for AI/ML models encompasses the following steps:

• Establish a Governance Structure

A formal governance committee with representatives from various departments (QA, IT, regulatory affairs, etc.) should be set up to oversee AI/ML initiatives. This team will be responsible for approving models, reviewing documentation, and ensuring adherence to documented policies.

• Define Security Protocols

Data security measures must be implemented to protect sensitive patient information and model integrity. Robust access controls, encryption techniques, and audit trails are necessary to comply with regulations like 21 CFR Part 11 and to prevent unauthorized access.

• Document Governance Processes

Ensure all governance processes are thoroughly documented, including roles and responsibilities, decision-making protocols, and escalation procedures. Such documentation will serve as a record for compliance audits and regulatory inspections.

Best Practices for Documentation and Audit Trails

Proper documentation and audit trails act as critical components of transparency and accountability in AI/ML model deployment. Consider the following best practices for effective documentation:

• Standardize Documentation Formats

Establish standard templates for various types of documentation, including model cards, change histories, audit reports, etc. Standard formats facilitate consistency and ease of understanding.

• Incorporate Version Control

Implement version control systems to track changes in model documentation, ensuring that each update is accurately logged with timestamps and author information. This practice enhances traceability.

• Maintain an Audit Trail

Diligently record all activities related to the model throughout its lifecycle, including training, validation, deployment, and monitoring. This documentation must be readily accessible for regulatory review and compliance verification.

• Train Team Members on Documentation Practices

Providing training and resources to team members on effective documentation practices fosters a culture of compliance and accountability while promoting best practices across departments.

Conclusion: The Importance of Rigorous Documentation in AI/ML Model Validation

As AI and ML become integral to modern pharmaceutical analytics, the significance of comprehensive documentation cannot be overstated. By adhering to regulatory requirements and establishing robust documentation practices—including change histories, model cards, bias testing, and governance frameworks—pharmaceutical organizations can ensure the reliability and ethical use of their AI/ML models. Ultimately, the goal is to enhance patient care while meeting stringent regulatory expectations. For further details on assisting in compliance, refer to resources from the FDA, the EMA, and WHO.